Abpro Corporation
Abpro Corporation (ABP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ABP · as of Jun 8, 2026
Key Statistics
Explore Abpro Corporation Data
abp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
abp competitorsABP
AEON
APM
BOLT
CING
CLRBStock Performance
Full HistoryAbout Abpro Corporation
Abpro Corporation Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element o…
what is abpro corporation · abp stock overview · abpro corporation company profile · who is abpro corporation ceo · abp NASDAQ · abpro corporation headquarters · abpro corporation business segments
About Stock Overview & Key Data
Abpro Corporation (ABP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 9, 2022. As of the latest trading session, ABP stock price is $0.52, with a market capitalization of $1.1M. The stock has returned -93.65% over the past 12 months and -87.63% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Abpro Corporation stock is Hold, with an average 12-month price target of $—. In fiscal year 2024, Abpro Corporation reported revenue of $183000.00 and net income of -$7.2M. For detailed data — including Abpro Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Abpro Corporation (ABP) stock price is $0.52. The stock is traded on NASDAQ under the ticker symbol ABP. The 52-week range is $0.11 – $18.03.